COVID-19: Zydus starts human dosing of its vaccine ‘ZyCoV-D’
Begins Adaptive Phase I/ II human clinical trials of its plasmid DNA vaccine, ZyCoV-D ZyCoV-D found safe, immunogenic, well-tolerated in the pre-clinical toxicity studies. The vaccine elicited high level of neutralizing antibodies in animal studies. Ahmedabad: Zydus, an innovation-driven global healthcare company, on Wednesday, announced that the Adaptive Phase I/ II human clinical trials of its […]